Publikationen von M. Labeur

Onofri, C.; Vila, G.; Wagner, L.; Correa-de Santana, E.; Labeur, M.; Luger, A.; Stalla, G. K.; Renner, U.: Involvement of the calcium-binding protein Secretagogin in pituitary adenoma hormone secretion. Experimental and Clinical Endocrinology & Diabetes 115 (Suppl. 1), S. S35 - S35 (2007)

Giacomini, D.; Acuna, M.; Gerez, J.; Nagashima, A. C.; Silberstein, S.; Paez-Pereda, M.; Labeur, M.; Theodoropoulou, M.; Renner, U.; Stalla, G. K. et al.; Arzt, E.: Pituitary action of cytokines: Focus on BMP-4 and gp130 family. Neuroendocrinology 85 (2), S. 94 - 100 (2007)

Castillo, V.; Giacomini, D.; Paez-Pereda, M.; Stalla, J.; Labeur, M.; Theodoropoulou, M.; Holsboer, F.; Grossman, A. B.; Stalla, G. K.; Arzt, E.: Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology 147 (9), S. 4438 - 4444 (2006)

Giacomini, D.; Páez-Pereda, M.; Theodoropoulou, M.; Labeur, M.; Refojo, D.; Gerez, J.; Chervin, A.; Berner, S.; Losa, M.; Buchfelder, M. et al.; Renner, U.; Stalla, G. K.; Arzt, E.: Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 147 (1), S. 247 - 256 (2006)

Kovalovsky, D.; Paez-Pereda, M.; Labeur, M.; Renner, U.; Holsboer, F.; Stalla, G. K.; Arzt, E.: Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. FEBS Letters 563 (1-3), S. 229 - 233 (2004)

Labeur, M.; Arzt, E.; Stalla, G. K.; Páez-Pereda, M.: New perspectives in the treatment of Cushing`s Syndrome. Current Drug Targets - Immune, Endocrine & Metabolic Disorders 4, S. 335 - 342 (2004)

Raiden, S.; Polack, E.; Nahmod, V.; Labeur, M.; Holsboer, F.; Arzt, E.: TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis. Journal of Clinical Immunology 15, S. 241 - 249 (1995)

Arzt, E.; Sauer, J.; Pollmächer, T.; Labeur, M.; Holsboer, F.; Reul, J. M. H. M.; Stalla, G. K.: Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology 134, S. 672 - 677 (1994)

Fuertes, M.; Gerez, J.; Haedo, M.; Giacomini, D.; Paez-Pereda, M.; Labeur, M.; Stalla, G. K.; Arzt, E.: Cytokines and Genes in Pituitary Tumorigenesis: RSUME Role in Cell Biology. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, S. 1 - 6 (Hg. Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)

Theodoropoulou, M.; Labeur, M.; Paez-Pereda, M.; Haedo, M.; Perone, M. J.; Renner, U.; Arzt, E.; Stalla, G. K.: Novel Medical Therapies for Pituitary Tumors. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, S. 158 - 164 (Hg. Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)

Giacomini, D.; Páez-Pereda, M.; Theodoropoulou, M.; Gerez, J.; Nagashima, A. C.; Chervin, A.; Berner, S.; Labeur, M.; Refojo, D.; Renner, U. et al.; Stalla, G. K.; Arzt, E.: Bone morphogenetic protein-4 control of pituitary pathophysiology. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, S. 22 - 31 (Hg. Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)

Labeur, M.; Theodoropoulou, M.; Sievers, C.; Paez-Pereda, M.; Castillo, V.; Arzt, E.; Stalla, G. K.: New aspects in the diagnosis and treatment of Cushing disease. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, S. 169 - 178 (Hg. Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)